Among the most popular portfolio startups of the fund, we may highlight Tisbury Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Medical, Pharmaceutical.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Pontifax, OrbiMed, HealthCap.
Related Funds
| Fund Name | Location |
| Aeternam Stella | China, Shanghai |
| Back in Black | Stockholm, Stockholm County, Sweden |
| Chicago ArchAngels | Chicago, Illinois, United States |
| Epicenter Technology | India, Maharashtra, Mumbai |
| Glacier Internet Investments | Florida, Miami, United States |
| Gridworks Partners | England, London, United Kingdom |
| Huadie Touzi | China, Guangdong, Jiangxi |
| JW Pharmaceuticals | - |
| KIDS HOLDINGS | Japan, Tokyo |
| Madanes Tech VC | - |
| MI Ventures | New York, New York, United States |
| OTS Service ManagementResearch & Consulting | Japan, Naha, Okinawa Prefecture |
| re.Mind Capital | Central Region, Malta, NA - Malta |
| Rimonim Fund | Israel, South Dakota, United States |
| Vidinovo | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tisbury Pharmaceuticals | $32M | 07 Jun 2017 | Beverly, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tisbury Pharmaceuticals | $32M | 07 Jun 2017 | Beverly, Massachusetts, United States |
